[Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
Efficacy and safety of sertraline (zoloft) have been assessed in 26 patients, aged from 7 to 15 years, with depressive states of different severity and psychopathological structure which are combined with obsessive-compulsive symptoms. Changes in patient's status are analyzed using psychometric scales during 6 weeks of treatment. It has been concluded that Zoloft is effective and safe drug for the treatment of mild to moderate depressive disorders concomitant to obsessive-compulsive disorders in children age.